文献速递乳房整形与再造

接受乳房再造手术患者的衰弱:系统综述与Meta分析

Frailty among patients undergoing breast reconstruction surgery: A systematic review and meta-analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2023-06-18

该系统综述与Meta分析检索截至2022年9月13日的四个数据库,纳入9项研究,评估衰弱对乳房再造术后并发症的预测价值。衰弱患者总体并发症(OR 1.52)、伤口并发症(OR 1.87)、再入院(OR 1.94)和再手术(OR 1.41)均显著高于非衰弱患者;前衰弱患者上述结局亦显著高于非衰弱患者。作者认为衰弱是乳房再造术后并发症的强预测因子,最常用衰弱指数为改良五条目衰弱指数(mFI-5),需在实践(尤其美国以外国家)中进一步研究。

要点

  • 衰弱患者乳房再造术后总体并发症、伤口并发症、再入院和再手术风险均显著高于非衰弱患者。
  • 前衰弱患者上述并发症风险亦显著高于非衰弱患者。
  • 立即自体组织再造的衰弱患者最易发生术后总体并发症。

核心结论

  • 衰弱是衰弱和前衰弱患者乳房再造术后并发症的强预测因子。
  • 最常用的衰弱指数为改良五条目衰弱指数(mFI-5)。
  • 需要更多研究评估衰弱在实践中的效用,尤其是在美国以外的国家。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE(PubMed)、Scopus、Web of Science和Embase截至2022年9月13日的相关研究。
  • 按PRISMA 2020声明标准进行系统综述与Meta分析,最终纳入9项研究。

主要发现

  • 衰弱患者较非衰弱患者总体并发症更高(OR 1.52,95%CI 1.17-1.97,I²=76%,p=0.002)。
  • 衰弱患者较非衰弱患者伤口并发症更高(OR 1.87,95%CI 1.56-2.26,I²=16%,p<0.0001)。
  • 衰弱患者较非衰弱患者再入院更高(OR 1.94,95%CI 1.61-2.34,I²=15%,p<0.0001)。
  • 衰弱患者较非衰弱患者再手术更高(OR 1.41,95%CI 1.12-1.77,I²=39%,p=0.003)。
  • 前衰弱患者较非衰弱患者总体并发症(OR 1.27,95%CI 1.13-1.41,I²=67%,p<0.001)、伤口并发症(OR 1.48,95%CI 1.33-1.66,I²=24%,p<0.0001)、再入院(OR 1.47,95%CI 1.34-1.61,I²=0%,p<0.0001)和再手术(OR 1.32,95%CI 1.23-1.42,I²=0%,p<0.0001)均更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要更多研究评估衰弱在实践中的效用,尤其是在美国以外的国家。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We conducted a systematic review and meta-analysis to evaluate the predictive value of frailty for predicting postsurgical complications in patients undergoing breast reconstruction surgery. METHODS: MEDLINE (PubMed), Scopus, Web of Science, and Embase were searched for relevant studies up to September 13, 2022. A systematic review and meta-analysis of studies were performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 statement criteria. RESULTS: Nine studies were included in this research. The rates of overall complications (odds ratio [OR] 1.52, 95% confidence interval [CI] 1.17-1.97, I2 = 76%; p = 0.002), wound complications (OR 1.87, 95% CI 1.56-2.26, I2 = 16%; p < 0.0001), readmissions (OR 1.94, 95% CI 1.61-2.34, I2 = 15%; p < 0.0001), and reoperations (OR 1.41, 95% CI 1.12-1.77, I2 = 39%; p = 0.003) were significantly greater in frail patients than in nonfrail undergoing breast reconstruction surgery. Furthermore, compared with nonfrail patients, this difference remained significantly higher among prefrail individuals (overall complications: OR 1.27, 95% CI 1.13-1.41, I2 = 67%; p < 0.001, wound complications: OR 1.48, 95% CI 1.33-1.66, I2 = 24%; p < 0.0001, readmission: OR 1.47, 95% CI 1.34-1.61, I2 = 0%; p < 0.0001, reoperation: OR 1.32, 95% CI 1.23-1.42, I2 = 0%; p < 0.0001). We found that frail patients undergoing immediate autologous reconstruction surgery are the most vulnerable to experiencing overall postoperative complications. CONCLUSION: Frailty is a strong predictor of postsurgical complications after breast reconstruction surgery in frail and prefrail patients. The most frailty index utilized was the modified five-item frailty index (mFI-5). More research is needed on this topic to assess the utility of frailty in practice, especially in countries other than the United States.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Shafiee A, Bahri RA, Rafiei MA, et al. Frailty among patients undergoing breast reconstruction surgery: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2023. PMID: 37422955. doi:10.1016/j.bjps.2023.06.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。